| High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial FS Larsen, LE Schmidt, C Bernsmeier, A Rasmussen, H Isoniemi, ... Journal of hepatology 64 (1), 69-78, 2016 | 606 | 2016 |
| Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK C Bernsmeier, OT Pop, A Singanayagam, E Triantafyllou, VC Patel, ... Gastroenterology 148 (3), 603-615. e14, 2015 | 272 | 2015 |
| the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease CA Woodhouse, VC Patel, A Singanayagam, DL Shawcross Alimentary pharmacology & therapeutics 47 (2), 192-202, 2018 | 216 | 2018 |
| Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry MH Sarafian, MR Lewis, A Pechlivanis, S Ralphs, MJW McPhail, VC Patel, ... Analytical chemistry 87 (19), 9662-9670, 2015 | 205 | 2015 |
| MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure E Triantafyllou, OT Pop, LA Possamai, A Wilhelm, E Liaskou, ... Gut 67 (2), 333-347, 2018 | 188 | 2018 |
| Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial R Caricchio, A Abbate, I Gordeev, J Meng, PY Hsue, T Neogi, R Arduino, ... Jama 326 (3), 230-239, 2021 | 159 | 2021 |
| CD14+ CD15− HLA-DR− myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure C Bernsmeier, E Triantafyllou, R Brenig, FJ Lebosse, A Singanayagam, ... gut 67 (6), 1155-1167, 2018 | 147 | 2018 |
| Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease A Riva, V Patel, A Kurioka, HC Jeffery, G Wright, S Tarff, D Shawcross, ... Gut 67 (5), 918-930, 2018 | 139 | 2018 |
| Balanced haemostasis with both hypo-and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure C Fisher, VC Patel, SH Stoy, A Singanayagam, J Adelmeijer, J Wendon, ... Journal of Critical Care 43, 54-60, 2018 | 107 | 2018 |
| Increased survival for patients with cirrhosis and organ failure in Liver Intensive Care and Validation of the chronic Liver Failure–Sequential Organ Failure Scoring System MJW McPhail, DL Shawcross, RD Abeles, A Chang, V Patel, GH Lee, ... Clinical Gastroenterology and Hepatology 13 (7), 1353-1360. e8, 2015 | 106 | 2015 |
| Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial VC Patel, S Lee, MJW McPhail, K Da Silva, S Guilly, A Zamalloa, ... Journal of hepatology 76 (2), 332-342, 2022 | 103 | 2022 |
| High-speed quantitative UPLC-MS analysis of multiple amines in human plasma and serum via precolumn derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate … N Gray, R Zia, A King, VC Patel, J Wendon, MJW McPhail, M Coen, ... Analytical chemistry 89 (4), 2478-2487, 2017 | 93 | 2017 |
| Multivariate metabotyping of plasma predicts survival in patients with decompensated cirrhosis MJW McPhail, DL Shawcross, MR Lewis, I Coltart, EJ Want, ... Journal of Hepatology 64 (5), 1058-1067, 2016 | 88 | 2016 |
| Mixed fibrinolytic phenotypes in decompensated cirrhosis and acute‐on‐chronic liver failure with hypofibrinolysis in those with complications and poor survival A Blasi, VC Patel, J Adelmeijer, S Azarian, MH Tejero, A Calvo, ... Hepatology 71 (4), 1381-1390, 2020 | 72 | 2020 |
| Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all‐cause admissions in patients on the liver transplant waiting list S Salehi, TH Tranah, S Lim, N Heaton, M Heneghan, V Aluvihare, ... Alimentary pharmacology & therapeutics 50 (4), 435-441, 2019 | 62 | 2019 |
| The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin‐α JG Orr, CJ Currie, E Berni, A Goel, KJ Moriarty, A Sinha, F Gordon, ... Liver International 36 (9), 1295-1303, 2016 | 53 | 2016 |
| Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome LR Rubel, LB Seeff, V Patel Archives of pathology & laboratory medicine 108 (5), 360-361, 1984 | 50 | 1984 |
| In vitro efficacy of pro‐and anticoagulant strategies in compensated and acutely ill patients with cirrhosis T Lisman, S Kleiss, VC Patel, C Fisher, J Adelmeijer, S Bos, ... Liver International 38 (11), 1988-1996, 2018 | 46 | 2018 |
| Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease T Lisman, B Arefaine, J Adelmeijer, A Zamalloa, E Corcoran, JG Smith, ... Journal of Thrombosis and Haemostasis 19 (1), 85-95, 2021 | 44 | 2021 |
| Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure C Bernsmeier, A Singanayagam, VC Patel, J Wendon, CG Antoniades Immunotherapy 7 (6), 641-654, 2015 | 39 | 2015 |
Evangelos TriantafyllouImperial College LondonVerificeret mail på imperial.ac.uk
